Source comparison
Research Selection Summary: Ipamorelin vs GHRP-2
Ipamorelin is the preferred GHS-R1a research tool when: GH-specific (non-cortisol-confounded) biology is the research question; the study involves immune, metabolic, or muscle protein endpoints where cortisol would confound; long-duration chronic protocols req
This comparison does not assign a generated winner or score.
- Ipamorelin is the preferred GHS-R1a research tool when: GH-specific (non-cortisol-confounded) biology is the research question; the study involves immune, metabolic, or muscle protein endpoints where cortisol would confound; long-duration chronic protocols require sustained receptor sensitivity; or when a clean GHS-R1a agonist control (without ACTH co-secretion) is needed to attribute effects specifically to GH rather than cortisol.
- GHRP-2 is the preferred research tool when: maximal GH peak amplitude is required (pituitary reserve testing, acute pharmacodynamic comparisons); higher peripheral GHS-R1a activation magnitude is the primary variable; or research specifically examines GHS-R1a biology at high receptor activation levels where affinity advantage matters. When ACTH confounding is a concern in GHRP-2 studies, adrenalectomised + physiological corticosterone replacement animals or mifepristone pre-treatment (10 mg/kg) are required controls.
- For studies requiring the highest possible GH output: GHRH analogue (CJC-1295) + GHRP-2 combination provides the maximal pharmacological GH stimulus; GHRH + Ipamorelin provides a comparable synergistic response (~90% of CJC+GHRP-2) with superior selectivity. The choice between these combinations depends on whether maximum GH magnitude or minimum confounding is the priority.
- 🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified Ipamorelin and GHRP-2 for research and laboratory use. View UK stock →
- William is a research analyst at Peptides Lab UK, specialising in research peptides, laboratory compounds, and sourcing standards for high-purity peptide products.